| # | Title | Journal | Year | Citations |
|---|
| 1 | The ‘risk environment’: a framework for understanding and reducing drug-related harm | International Journal of Drug Policy | 2002 | 903 |
| 2 | Risk environments and drug harms: A social science for harm reduction approach | International Journal of Drug Policy | 2009 | 697 |
| 3 | The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis | International Journal of Drug Policy | 2019 | 395 |
| 4 | “Every ‘Never’ I Ever Said Came True”: Transitions from opioid pills to heroin injecting | International Journal of Drug Policy | 2014 | 389 |
| 5 | Initiation into prescription opioid misuse amongst young injection drug users | International Journal of Drug Policy | 2012 | 380 |
| 6 | Fentanyl in the US heroin supply: A rapidly changing risk environment | International Journal of Drug Policy | 2017 | 337 |
| 7 | Stigma at every turn: Health services experiences among people who inject drugs | International Journal of Drug Policy | 2018 | 317 |
| 8 | Global estimates of prevalence of HCV infection among injecting drug users | International Journal of Drug Policy | 2007 | 305 |
| 9 | Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms | International Journal of Drug Policy | 2010 | 288 |
| 10 | Chemsex behaviours among men who have sex with men: A systematic review of the literature | International Journal of Drug Policy | 2019 | 283 |
| 11 | Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use | International Journal of Drug Policy | 2013 | 257 |
| 12 | Re-framing ‘binge drinking’ as calculated hedonism: Empirical evidence from the UK | International Journal of Drug Policy | 2008 | 249 |
| 13 | The public health and social impacts of drug market enforcement: A review of the evidence | International Journal of Drug Policy | 2005 | 245 |
| 14 | Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness | International Journal of Drug Policy | 2014 | 238 |
| 15 | Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic | International Journal of Drug Policy | 2017 | 225 |
| 16 | “Chemsex” and harm reduction need among gay men in South London | International Journal of Drug Policy | 2015 | 221 |
| 17 | The impact of a police crackdown on a street drug scene: evidence from the street | International Journal of Drug Policy | 2002 | 219 |
| 18 | Opioid-related mortality in rural America: Geographic heterogeneity and intervention strategies | International Journal of Drug Policy | 2018 | 216 |
| 19 | Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’ | International Journal of Drug Policy | 2017 | 211 |
| 20 | Mapping violence and policing as an environmental–structural barrier to health service and syringe availability among substance-using women in street-level sex work | International Journal of Drug Policy | 2008 | 207 |
| 21 | Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis | International Journal of Drug Policy | 2018 | 206 |
| 22 | Effect of drug law enforcement on drug market violence: A systematic review | International Journal of Drug Policy | 2011 | 205 |
| 23 | Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation | International Journal of Drug Policy | 2006 | 202 |
| 24 | Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients | International Journal of Drug Policy | 2017 | 202 |
| 25 | The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy | International Journal of Drug Policy | 2010 | 191 |
| 26 | Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States | International Journal of Drug Policy | 2019 | 189 |
| 27 | Smoking, vaping, eating: Is legalization impacting the way people use cannabis? | International Journal of Drug Policy | 2016 | 188 |
| 28 | Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups | International Journal of Drug Policy | 2007 | 182 |
| 29 | The pleasure in context | International Journal of Drug Policy | 2008 | 177 |
| 30 | Erasing pleasure from public discourse on illicit drugs: On the creation and reproduction of an absence | International Journal of Drug Policy | 2008 | 177 |
| 31 | Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS) | International Journal of Drug Policy | 2016 | 175 |
| 32 | Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study | International Journal of Drug Policy | 2017 | 175 |
| 33 | Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading | International Journal of Drug Policy | 2014 | 174 |
| 34 | Critiques of harm reduction, morality and the promise of human rights | International Journal of Drug Policy | 2003 | 173 |
| 35 | Public injection settings in Vancouver: Physical environment, social context and risk | International Journal of Drug Policy | 2007 | 173 |
| 36 | Injecting drug users: A stigmatised and stigmatising population | International Journal of Drug Policy | 2009 | 173 |
| 37 | Rapid scale up of harm reduction in China | International Journal of Drug Policy | 2007 | 170 |
| 38 | ‘Surfing the Silk Road’: A study of users’ experiences | International Journal of Drug Policy | 2013 | 168 |
| 39 | ‘Silk Road’, the virtual drug marketplace: A single case study of user experiences | International Journal of Drug Policy | 2013 | 168 |
| 40 | Quality of life among opiate-dependent individuals: A review of the literature | International Journal of Drug Policy | 2010 | 165 |
| 41 | Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets | International Journal of Drug Policy | 2016 | 165 |
| 42 | The adverse health effects of cannabis use: What are they, and what are their implications for policy? | International Journal of Drug Policy | 2009 | 160 |
| 43 | The globalization of ayahuasca: Harm reduction or benefit maximization? | International Journal of Drug Policy | 2008 | 159 |
| 44 | Recommendations for the management of hepatitis C virus infection among people who inject drugs | International Journal of Drug Policy | 2015 | 159 |
| 45 | The effectiveness of compulsory drug treatment: A systematic review | International Journal of Drug Policy | 2016 | 159 |
| 46 | Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review | International Journal of Drug Policy | 2017 | 158 |
| 47 | Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics | International Journal of Drug Policy | 2017 | 157 |
| 48 | Today’s fentanyl crisis: Prohibition’s Iron Law, revisited | International Journal of Drug Policy | 2017 | 156 |
| 49 | Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA | International Journal of Drug Policy | 2010 | 154 |
| 50 | The new policy mix: Alcohol, harm minimisation, and determined drunkenness in contemporary society | International Journal of Drug Policy | 2006 | 152 |
